Management of Immunotherapy Toxicity in NSCLC

Inaugural Africa Conference: Finding Parallels Among Disparate Realities

5th AACR-IASLC International Joint Conference: Translational Progress through Basic Research

Studies Indicate Expanding Benefit of Checkpoint Inhibitors

Bronchoscopy Ultrasound and Navigational Bronchoscopy Finally Arrive in Peru

IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology

IASLC WCLC 2017 Presidential Symposium Presents Leading Lung Cancer Research

Exploring the Potential of Immuno-oncology Combination Therapy

Q & A with Yi-Long Wu, MD

Adjuvant Gefitinib Extended Disease-Free Survival in Patients With Stage II/IIIA Non-Small Cell Lung Cancer With EGFR-Activating Mutations

Adjuvant Gefitinib Extended Disease-Free Survival in Patients With Stage II/IIIA Non-Small Cell Lung Cancer With EGFR-Activating Mutations

IASLC 18th World Conference on Lung Cancer